154 related articles for article (PubMed ID: 28762760)
1. Outsourcing of bioanalysis at GSK: a hybrid approach with a robust support model.
Abberley L
Bioanalysis; 2017 Aug; 9(15):1139-1144. PubMed ID: 28762760
[No Abstract] [Full Text] [Related]
2. Future trends in outsourcing: a summary of the Bioanalysis Zone Survey.
Craddock A; Nadarajah S
Bioanalysis; 2017 Aug; 9(15):1127-1129. PubMed ID: 28766363
[No Abstract] [Full Text] [Related]
3. Bioanalytical outsourcing: transitioning from Pharma to CRO.
Hayes R
Bioanalysis; 2017 Aug; 9(15):1149-1152. PubMed ID: 28763257
[No Abstract] [Full Text] [Related]
4. Bioanalytical outsourcing models in pharmaceutical companies.
Zimmer D
Bioanalysis; 2017 Aug; 9(15):1145-1148. PubMed ID: 28763250
[No Abstract] [Full Text] [Related]
5. Bioanalytical outsourcing: the two sides of the medal.
Zimmer D
Bioanalysis; 2013 Sep; 5(17):2095-9. PubMed ID: 23962249
[No Abstract] [Full Text] [Related]
6. Outsourcing lead optimization: the eye of the storm.
Clark DE
Drug Discov Today; 2011 Feb; 16(3-4):147-57. PubMed ID: 21145413
[TBL] [Abstract][Full Text] [Related]
7. Biopharma CRO industry in China: landscape and opportunities.
Xia C; Gautam A
Drug Discov Today; 2015 Jul; 20(7):794-8. PubMed ID: 25701282
[TBL] [Abstract][Full Text] [Related]
8. Current status of bioanalytical outsourcing: a pharma perspective.
Bioanalysis; 2017 Aug; 9(15):1165-1169. PubMed ID: 28795582
[TBL] [Abstract][Full Text] [Related]
9. The quiet revolution: outsourcing in pharma.
Crossley R
Drug Discov Today; 2004 Aug; 9(16):694. PubMed ID: 15341780
[No Abstract] [Full Text] [Related]
10. Outsourcing is in.
Landhuis E
Nature; 2018 Apr; 556(7700):263-265. PubMed ID: 29643487
[No Abstract] [Full Text] [Related]
11. A community of practice approach to bioanalysis delivery: the role of the Preclinical Bioanalysis and Toxicokinetics department at AstraZeneca.
Wilson A; Silvester S; Woods K
Bioanalysis; 2014 May; 6(10):1329-37. PubMed ID: 24958117
[TBL] [Abstract][Full Text] [Related]
12. Pharmaceutical futures: made in China?
Cyranoski D
Nature; 2008 Oct; 455(7217):1168-70. PubMed ID: 18971994
[No Abstract] [Full Text] [Related]
13. Outsourcing discovery.
Mallapaty S
Nature; 2017 Dec; 552(7683):S5. PubMed ID: 29219992
[No Abstract] [Full Text] [Related]
14. One lab, two firms, many possibilities: On R&D outsourcing in the biopharmaceutical industry.
Billette de Villemeur E; Versaevel B
J Health Econ; 2019 May; 65():260-283. PubMed ID: 31158785
[TBL] [Abstract][Full Text] [Related]
15. Changing shape: evolving an outsourced bioanalytical strategy to support the changing needs of drug development.
Stovold C; Milligan F; Hawthorne G; Pattison C; Wilson A
Bioanalysis; 2017 Aug; 9(15):1135-1137. PubMed ID: 28763237
[No Abstract] [Full Text] [Related]
16. Outsourcing unit dose packaging.
Sanborn MD
Am J Health Syst Pharm; 2010 Jul; 67(13):1116-7. PubMed ID: 20554599
[No Abstract] [Full Text] [Related]
17. Outsourcing chemical synthesis in the drug discovery process.
Festel G
Drug Discov Today; 2011 Mar; 16(5-6):237-43. PubMed ID: 21262378
[TBL] [Abstract][Full Text] [Related]
18. The evolution of the Pharma-CRO working relationship: AstraZeneca and Covance.
Bioanalysis; 2017 Aug; 9(15):1171-1174. PubMed ID: 28795581
[TBL] [Abstract][Full Text] [Related]
19. Meeting the challenges of bioanalytical outsourcing: understanding the hidden cost of price pressure.
Bennett P
Bioanalysis; 2011 Nov; 3(22):2491-3. PubMed ID: 22122596
[No Abstract] [Full Text] [Related]
20. Biomanufacturing, from bust to boom...to bubble?
Thiel KA
Nat Biotechnol; 2004 Nov; 22(11):1365-72. PubMed ID: 15529157
[No Abstract] [Full Text] [Related]
[Next] [New Search]
